
zzso stem cell rescue zzso following high-dose zzso chemotherapy is considered to be a therapeutic option for many multiple myeloma zzso zzso however zzso post zzso presents a major zzso The zzso potential of zzso has been previously demonstrated and is currently undergoing phase I zzso clinical trials for zzso and phase zzso clinical trials for solid zzso Here we tested the hypothesis that zzso can successfully purge zzso in a zzso model that partially zzso human zzso zzso zzso zzso zzso and zzso human myeloma cell lines were exposed to zzso and zzso was zzso zzso product zzso with zzso cells was zzso with live zzso zzso or dead virus zzso and zzso efficacy was monitored via flow zzso reverse zzso zzso and disease zzso in non obese zzso combined immune deficient zzso zzso zzso zzso zzso was seen with zzso zzso and zzso and the complete ex zzso zzso achieved with zzso zzso was confirmed by flow zzso zzso and absence of disease zzso in zzso Mice that received zzso zzso exhibited zzso survival in comparison to mice that received zzso zzso zzso unique ability to kill zzso while sparing zzso stem cells places it as an attractive zzso agent for zzso during zzso 

